GH Research PLC (GHRS)

Business: GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders.

IPO Date: 25-Jun-2021

Co-Founder & Non-Exec. Chairman: Mr. Florian Schonharting M.Sc. (Econ)

Co-Founder & CEO: Mr. Theis Terwey M.D.

Listing: NASDAQ: GHRS

Country: Ireland

Headquarters: Dublin,

Website: https://www.ghres.com

Market cap: $572.23 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-13.82 Mln

Cash: $270.75 Mln

Total Debt: $0.00 Mln

Insider's Holding: 41.32%

Liquidity: Low

52 Week range: $8.72 - 30.43

Shares outstanding: 52,020,800